Symbols

BBP

Virtus Biotech ETF·ARCA

--(--)

Key Stats

Assets Under Management

47.27MUSD

Fund Flow (1Y)

18.58MUSD

Dividend Yield

Discount / Premium to NAV

0.21%

Shares Outstanding

600.00K

Expense Ratio

0.34%

About Virtus Biotech ETF

Issuer

Virtus Investment Advisers, LLC

Brand

Virtus

Home Page

https://www.virtus.com/products/virtus-biotech-etf#shareclass.620/period.quarterly

Inception Date

Dec 16, 2014

Structure

Open-Ended Fund

Index Tracked

LifeSci Biotechnology Products Index

Management Style

Passive

Dividend Treatment

Distributes

Distribution Tax Treatment

Qualified dividends

Income Tax Type

Capital Gains

Max ST Capital Gains Rate

39.60%

Max LT Capital Gains Rate

20.00%

Primary Advisor

Virtus Advisers LLC

Distributor

VP Distributors LLC

BBP offers a different approach to biotech investing by handpicking firms whose lead drugs are on its product stage or those firms that have attained FDA approval for their leading drug. Stocks must earn a majority of their revenue from the research and development and/or marketing and sale of novel drugs or other therapeutics used in the treatment of human diseases. The fund is offered by BioShares alongside launched a sister fund, BBC, which targets biotech firms in the clinical trial stage. The index is reconstituted on a semi-annual basis.